In The News
DePuy Hip Implant Recall

$8.3 Million Reasons to Choose Dean as your Attorney
Metal on Metal Hip Device Recall - Depuy

Dean A. Goetz and the Gomez Law Firm were the attorneys for Mr. Loren Kranksy, the Plaintiff in the first Depuy trial in the USA. 3/6/13 at 9:38 a.m. PST A jury found Depuy liable to Mr. Loren Bill Kransky today in a Los Angeles Superior Court. FIRST verdict in the USA against Depuy for $8,328,000. We Are The Kransky Lawyers. Kranksy vs. Depuy and Johnson and Johnson, Los Angeles County Superior Court Case #BC456086.

It took three and one half more years for this to finally end for Mr. Kransky's family, on 7/21/16 Court of Appeals Upholds Kransky v. Depuy.

November 2017: Dean Goetz with Mr. Kransky's full legal team Nominated (PDF press release) for Consumer Attorneys of California Attorney of the Year 2017  for our work in Kransky vs. Depuy, and Mr. Kransky's long road to justice.

The Walking Wounded - Dean Goetz interviewed on ABC (Australia ABC, a show similar to USA "60 Minutes") Investigative Report - watch the whole investigative story on Depuy, aired 5/26/14, "Reporter Quentin McDermott reveals how a healthcare giant deceived doctors and patients using its ASR hip replacement implant." Australian Depuy class action cases go to trial in 2015, and those injured by their hip devices are now armed with what came out in Mr. Kransky's trial..


Related Informational Links:

New York Times

Johnson & Johnson Recalls Hip Implants. NATASHA SINGER

August 26, 2010

The high early failure rate of the ASR implants was reported this year in several articles in The New York Times. These devices have come under scrutiny over the last few years because they are part of a category of implants called metal-on-metal bearings, which can generate debris from wear, causing inflammation and tissue damage in certain patients.

New York Times

With Warning, a Hip Device Is Withdrawn. BARRY MEIER

March 9, 2010

Just last month, in an interview, DePuy officials defended the ASR’s track record, saying its performance equaled that of competing devices. Those officials also said that the company was phasing out sales of the ASR for commercial reasons, not because of any safety issues.

New York Times

As Use of Metal-on-Metal Hip Implants Grows, Studies Raise Concerns. BARRY MEIER

March 3, 2010

About a decade ago, just as a new generation of metal-on-metal artificial hips were starting to be used, some studies noted their potential to produce high levels of metallic ions, causing what were thought to be allergic reactions in some patients. But in the last two years, broader concerns have emerged amid research reports that the metal debris can ignite severe inflammatory reactions that can damage or destroy muscles, tendons and other soft tissue.

New York Times

Concerns Over 'Metal on Metal' Hip Implants


March 3, 2010

The cause and the scope of the problem are not clear. But studies in recent years indicate that in some cases the devices can quickly begin to wear, generating high volumes of metallic debris that is absorbed into a patient's body. That situation can touch off inflammatory reactions that cause pain in the groin, death of tissue in the hip joint and loss of surrounding bone.

New York Times

The Implants Loophole.


December 16, 2010

A recently recalled artificial hip made by a unit of Johnson & Johnson, designed to last 15 years or more, is failing worldwide at unusually high rates after just a few years. [...] Until late summer, officials at the Johnson & Johnson unit, DePuy Orthopaedics, the largest maker of replacement hips worldwide, maintained that the A.S.R. was performing on a par with competing devices. But interviews with doctors indicate that DePuy received repeated warnings that the implant was failing and that surgeons were abandoning it.

The Wall Street Journal

DePuy's Hip Replacement: The New Big Thing in Product Liability Suits? DIONNE SEARCEY

December 17, 2010

Many patients who have received the implant claim to have developed curious pain, and surgeons who have replaced the implant say they have found mysterious masses of dead tissue near patients' thighs. Some patients allege that they have high levels of cobalt ions in their blood, prompting them to fear they risk poisoning themselves.

Los Angeles Times

J & J gets FDA warning on marketing


August 24, 2010

In a letter to the company, the FDA wrote that DePuy is marketing its Corail Hip System for two unapproved uses, and promoting those uses in an online brochure.

New York Times

Health System Bears Cost of Implants With No Warranties


April 2, 2010

For Mr. Morris, the procedure he underwent in January was his third hip replacement since 2006. The first one failed that same year. In mid-2006, he received another replacement. For about a year, he felt good, but then his joints became so painful and inflamed that he thought he might be dying [...] His employer's insurance covered most of his costs, but Mr. Morris estimates that his co-payments and other out-of-pocket costs were well over $10,000 for the initial replacement and the two additional surgeries.

Articles published during the first Depuy trial on emerging information:

Articles about Depuy recall leading up to trial: